08/06/2025
7:29 AM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
07/23/2025
4:27 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/25/2025
4:16 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
06/25/2025
3:01 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2025
4:17 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2025
11:02 AM | Harraden Circle Investments, LLC (Filed by)
Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
| Form SCHEDULE 13G/A | |
04/11/2025
3:00 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/01/2025
4:11 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025
6:00 AM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2025
4:27 PM | Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
Psyence Group Inc. (Filed by)
| Form SCHEDULE 13D/A | |
03/16/2025
11:15 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for PBM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Psyence Biomedical and its competitors with MarketBeat's FREE daily newsletter. |
03/04/2025
3:46 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
02/14/2025
6:00 AM | Harraden Circle Investments, LLC (Filed by)
Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
7:00 PM | Hudson Bay Capital Management LP (Filed by)
Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:22 PM | Hudson Bay Capital Management LP (Filed by)
Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
| Form SCHEDULE 13G | |
01/30/2025
11:15 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form EFFECT | |
01/24/2025
5:05 AM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
01/23/2025
3:01 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025
4:05 PM | AdvisorShares Trust (Filed by)
Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
| Form SCHEDULE 13G/A | |
01/01/2025
11:15 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form EFFECT | |
12/31/2024
3:27 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 424B3 | |
12/31/2024
3:01 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/23/2024
4:29 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2024
3:16 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
12/19/2024
7:00 AM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2024
3:27 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2024
8:16 AM | Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
White Lion Capital LLC (Filed by)
| Form SC 13G | |
12/09/2024
12:36 PM | Harraden Circle Investments, LLC (Filed by)
Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
| Form SC 13G/A | |
12/04/2024
6:34 AM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2024
6:04 AM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024
8:41 AM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024
7:05 AM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024
8:21 AM | Harraden Circle Investments, LLC (Filed by)
Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
| Form SC 13G/A | |
11/12/2024
12:45 PM | AdvisorShares Trust (Filed by)
Psyence Biomedical (Subject)
PSYENCE BIOMEDICAL LTD. (Subject)
| Form SC 13G | |
11/01/2024
3:07 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024
4:02 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
10/23/2024
3:01 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024
11:15 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form EFFECT | |
10/10/2024
4:05 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 424B3 | |
10/08/2024
3:05 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024
4:00 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
An $8 trillion-dollar discovery 17,000 ft underwater (Ad) A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems.
While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone. See the name and ticker behind America’s $16 trillion resource push. |
09/13/2024
4:00 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024
3:31 PM | Psyence Biomedical (Filer)
PSYENCE BIOMEDICAL LTD. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
